// App-Quantinova.ai

4999 : Cellular mechanism of action of bispecific T-cell engager (BiTE) antibody constructs targeting Folate Receptor 1

Researchers

Presenter

  • Julie M. Bailis

Principal Investigators

  • Jessica N. Orf

  • Alexander Sternjak

  • Brian Belmontes

  • Ryan Case

  • Natalia Grinberg

  • Wesley Chang

  • Beth Hinkle

  • Matthias Friedrich

Medical Centers

  • Amgen Inc, South San Francisco, CA

  • Amgen, Inc., Munich, Germany

  • Amgen Inc, Thousand Oaks, CA

Locations

  • United States

  • Germany

Companies

  • Amgen Inc.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Gynaecological cancer

  • Ovarian cancer

  • Solid malignancies

Biomarkers

  • C-C Motif Chemokine Ligand 2

  • Cluster of Differentiation 25

  • Cluster of Differentiation 2AP

  • Cluster of differentiation 69

  • Folate

  • Folate Receptor 1

  • Interleukin 6

  • Tumor necrosis factor

Drug/Treatment

  • Blinatumomab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved